Skip to content
MedsAcross

Medicine

Tosymra 10 mg/0.1 mL nasal spray

Sumatriptan · Nasal · Tonix Medicines
Available on requestPrescription onlyUS FDA

Tosymra 10 mg/0.1 mL nasal spray is a prescription medicine containing Sumatriptan for nasal use, marketed by Tonix Medicines, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Do not store in the refrigerator or freezer. Store at 20° to 25°C (68° to…

Key facts

Active ingredient (INN)
Sumatriptan
Brand
Tosymra
Strength
10 mg/0.1 mL
Dosage form
Nasal spray
Route
Nasal
Packs
6 blister pack, 1 blister pack
Marketing authorisation holder
Tonix Medicines
Manufacturers
Tonix MedicinesUpsher-Smith Laboratories
Origin register
US FDA, United States
Storage
Do not store in the refrigerator or freezer. Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
N02CC01 Sumatriptan
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
8 July 2019
Identifiers
RxCUI 401978, 2178073DailyMed set ID 015a5cf9-f246-48bc-b91e-cd730a53d8aa, d9f682f0-d50a-4fe6-ab1b-e5a7ec27b3a5NDC 0245-0812, 70792-812Application NDA210884

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
6 blister pack in 1 carton / 1 bottle, spray in 1 blister pack / .1 mL in 1 bottle, spray70792-812-61Tonix Medicines1 July 2024
1 blister pack in 1 carton / 1 bottle, spray in 1 blister pack / .1 mL in 1 bottle, spray70792-812-89Tonix Medicines1 April 2025
6 blister pack in 1 carton / 1 bottle, spray in 1 blister pack / .1 mL in 1 bottle, spray0245-0812-61Upsher-Smith Laboratories1 September 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 28 December 1992Drugs@FDA
EU (EMA)RefusedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Sumatriptan

Clinical summary

Sumatriptan is a serotonin-1b and serotonin-1d receptor agonist indicated in adults for the acute treatment of migraine, with or without aura, and the acute treatment of cluster headache, among other approved uses. MedsAcross supplies Sumatriptan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Sumatriptan

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Tosymra 10 mg/0.1 mL nasal spray for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.